Tag: Comment

The perils of pharma M&A (Bloomberg)

Another Roche setback (CNBC)

Turning world-leading science into medicines (Daily Telegraph)

EU probe Bayer’s proposed merger (CNBC)

GSK’s evolving business model (Daily Telegraph)

Novartis’ Gene Therapy progress (CNBC)

Roche’s oncology setback (CNBC)

What the American Health Care Act could mean for pharma (CNBC)

Bayer’s outlook following its recent acquisition (CNBC)

Private equity firms bid on Stada (In Vivo)

Resources

Insights

Discover new perspectives and approaches to address industry challenges

Client Stories

Find out what our clients have achieved with us, and how

Media

Stay up to date with our press comment and specialist journal articles